Published in Ann Thorac Surg on December 25, 2012
Reply: To PMID 21704299. Ann Thorac Surg (2012) 0.75
Metabolic Functions of the Lung, Disorders and Associated Pathologies. J Clin Med Res (2016) 0.75
Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought. Lung (2017) 0.75
Is sublobar resection sufficient for carcinoid tumors? Ann Thorac Surg (2011) 2.93
Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol (2012) 2.23
Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg (2010) 2.08
Persistent air leak after pulmonary resection: the water-valve "foam" problem. Ann Thorac Surg (2004) 2.03
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res (2004) 1.77
Retracted Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment. Am J Respir Crit Care Med (2009) 1.74
Single-centre 40-year results of redo operation for recurrent thymomas. Eur J Cardiothorac Surg (2011) 1.52
Long-term results after treatment for recurrent thymoma: a multicenter analysis. J Thorac Oncol (2014) 1.47
Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results. Ann Thorac Surg (2012) 1.46
Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem (2009) 1.41
Intrathoracic gastric perforation: a late complication of an unknown postpartum recurrent hiatal hernia. Interact Cardiovasc Thorac Surg (2012) 1.39
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys (2010) 1.25
Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med (2012) 1.24
Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer (2007) 1.21
Is 18F-FDG-PET/CT really able to differentiate between malignant and benign solitary fibrous tumor of the pleura? Clin Imaging (2013) 1.17
EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation. Int J Med Sci (2013) 1.14
Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer. Oncogene (2005) 1.11
Early stage non-small-cell lung cancer: surgical implications of the new adenocarcinoma classification. J Thorac Oncol (2013) 1.10
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol (2002) 1.09
Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer (2007) 1.08
Are We at the Dusk of Mediastinoscopy in Modern Clinical Practice? J Thorac Oncol (2015) 1.08
N2 nodal involvement in multiple primary lung cancer: really an exclusion criterion? Chest (2013) 1.07
Bronchial carcinoid tumors causing Cushing's syndrome: an insidious disease. Ann Thorac Surg (2013) 1.07
Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series. J Thorac Oncol (2012) 1.07
Surgery and Survival of Patients with Diagnosis of Malignant Pleural Mesothelioma. J Thorac Oncol (2015) 1.07
Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors? Ann Nucl Med (2014) 1.06
Microdrainage via open technique in severe subcutaneous emphysema. Chest (2003) 1.02
Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases. Cancer Lett (2010) 1.01
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. Ann Thorac Surg (2012) 1.01
The cholinergic system and cancer. Semin Cancer Biol (2007) 1.00
Successful early treatment of Boerhaave's syndrome by endoscopic placement of a temporary self-expandable plastic stent without fluoroscopy. Gastrointest Endosc (2003) 1.00
Chest wall giant lipoma with a thirty-year history. Interact Cardiovasc Thorac Surg (2012) 0.99
Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug development. Int J Cancer (2008) 0.98
alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma? Drug Discov Today (2009) 0.97
Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. J Clin Oncol (2002) 0.97
Nicotine, lung and cancer. Anticancer Agents Med Chem (2007) 0.97
Nicotine: specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol (2011) 0.96
PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol (2014) 0.95
Post-esophagectomy anastomotic leaks. The role of the anastomotic location. Ann Ital Chir (2013) 0.95
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin Nucl Med (2015) 0.94
Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategies. Curr Med Chem Anticancer Agents (2004) 0.92
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res (2008) 0.91
Pulmonary metastases from parachordoma. Ann Thorac Surg (2009) 0.91
Pulmonary metastases: can accurate radiological evaluation avoid thoracotomic approach? Eur J Cardiothorac Surg (2002) 0.91
Rationale and clinical benefits of an intensive long-term pulmonary rehabilitation program after oesophagectomy: preliminary report. Multidiscip Respir Med (2012) 0.90
Osteopontin is not a specific marker in malignant pleural mesothelioma. Int J Biol Markers (2009) 0.90
Use of pharmacotherapy for smoking cessation in Italy. Arch Intern Med (2009) 0.90
Transoesophageal endoscopic ultrasound-guided fine-needle aspiration of pleural effusion for the staging of non-small cell lung cancer. Interact Cardiovasc Thorac Surg (2013) 0.90
Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study. Eur J Cardiothorac Surg (2013) 0.89
P4 medicine needs P4 education. Curr Pharm Des (2014) 0.89
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression. Int J Cancer (2008) 0.89
Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis. Eur J Cardiothorac Surg (2014) 0.88
Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt. Eur J Cardiothorac Surg (2011) 0.88